104 related articles for article (PubMed ID: 3157051)
1. Cytochemical detection of estrogen receptors in mammary tumours.
Gădăleanu V; Gavrilescu TH
Morphol Embryol (Bucur); 1985; 31(1):31-4. PubMed ID: 3157051
[TBL] [Abstract][Full Text] [Related]
2. Comparing the clinical, histopathological and myoepithelial features of estrogen receptor positive and negative mammary carcinomas.
Gucin Z; Aksoy B; Gunver F; Pasaoglu E; Bahadir F
Saudi Med J; 2006 Apr; 27(4):470-6. PubMed ID: 16598322
[TBL] [Abstract][Full Text] [Related]
3. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.
Charpin C; Martin PM; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Toga M
Cancer Res; 1986 Aug; 46(8 Suppl):4271s-4277s. PubMed ID: 3524808
[TBL] [Abstract][Full Text] [Related]
5. In vitro estrogen-binding by human breast carcinomas.
Mobbs BG; Johnson IE
Can Med Assoc J; 1976 Feb; 114(3):216-9. PubMed ID: 1032352
[TBL] [Abstract][Full Text] [Related]
6. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
7. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
[TBL] [Abstract][Full Text] [Related]
8. Plasma oestradiol-17B and oestrogen receptors in mammary tumours among Africans.
Okech MO; Orinda DA; Gatei DG; Wasunna AO
East Afr Med J; 1977 Nov; 54(11):615-20. PubMed ID: 614126
[No Abstract] [Full Text] [Related]
9. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
Pewnim T; Adams JB; Ho KP
Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
[TBL] [Abstract][Full Text] [Related]
10. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
Kurbel S
Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713
[TBL] [Abstract][Full Text] [Related]
11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
12. High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?
Navani S; Bhaduri AS
Indian J Pathol Microbiol; 2005 Apr; 48(2):199-201. PubMed ID: 16758664
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
Keshgegian AA; Cnaan A
Arch Pathol Lab Med; 1996 Oct; 120(10):970-3. PubMed ID: 12046611
[TBL] [Abstract][Full Text] [Related]
14. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
Looi LM; Cheah PL
Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
[TBL] [Abstract][Full Text] [Related]
15. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
Kronblad A; Helczynska K; Nielsen NH; Påhlman E; Emdin S; Påhlman S; Landberg G
In Vivo; 2003; 17(4):311-8. PubMed ID: 12929585
[TBL] [Abstract][Full Text] [Related]
16. The correlation of cytologic grade and steroid receptor content in effusions of metastatic breast carcinoma.
Mossler JA; McCarty KS; Johnston WW
Acta Cytol; 1981; 25(6):653-8. PubMed ID: 6947669
[TBL] [Abstract][Full Text] [Related]
17. [Problems posed by the morphologic demonstration of estrogen receptors].
Mazabrey D; Jozan S; Marques B; David JF
Bull Assoc Anat (Nancy); 1986 Sep; 70(210):25-34. PubMed ID: 3327546
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of estrogen receptors in mammary carcinomas. Is immunocytochemical determination after formalin fixation sufficient?].
Haugen OA; Aasmundstad T; Johannesen E; Ytterhus B; Nervik I
Tidsskr Nor Laegeforen; 1993 Mar; 113(8):944-6. PubMed ID: 8470071
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor analysis on needle aspirates from human mammary carcinoma.
Silfverswärd C; Humla S
Acta Cytol; 1980; 24(1):54-7. PubMed ID: 6928336
[TBL] [Abstract][Full Text] [Related]
20. Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies.
Gerdes J; Pickartz H; Brotherton J; Hammerstein J; Weitzel H; Stein H
Am J Pathol; 1987 Dec; 129(3):486-92. PubMed ID: 3501245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
